Chen Melanie T, Krzyszczyk Danielle M, Brown Alison G M, Kressin Nancy, Terrin Norma, Hanchate Amresh, Suzukida Jillian, Kher Sucharita, Price Lori Lyn, LeClair Amy M, Byhoff Elena, Freund Karen M
The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA.
National Heart, Lung, and Blood Institute, National Institutes of Health, 31 Center Drive, Bethesda, MD, 20892, USA.
J Racial Ethn Health Disparities. 2022 Jun;9(3):1075-1082. doi: 10.1007/s40615-021-01046-z. Epub 2021 May 19.
Racial/ethnic disparities in glycemic control-a key diabetes outcome measure-continue to widen, even though the overall prevalence of glycemic control in the US has improved. Health insurance coverage may be associated with improved glycemic control, but few studies examine effects during a period of policy change. We assessed changes in glycemic control by racial/ethnic groups following the Massachusetts Health Insurance Reform for patients at two urban safety-net academic health systems between January 2005 and December 2013. We analyzed outcomes for three measures of poor glycemic control: 1) lack of a hemoglobin A1C (A1C) measure during a 6-month period; 2) A1C >8%; 3) A1C >9% before, during, and after implementation of insurance reform. We did not find increased rates of A1C monitoring or control following insurance reform overall or for specific racial/ethnic groups. We found evidence of worsened, not improved, glycemic control in some racial/ethnic groups in the post-reform period. The expansion of affordable insurance coverage was not associated with improved glycemic control in vulnerable populations.
血糖控制(一项关键的糖尿病预后指标)方面的种族/族裔差异持续扩大,尽管美国血糖控制的总体患病率有所改善。医疗保险覆盖范围可能与血糖控制的改善有关,但很少有研究考察政策变化期间的影响。我们评估了2005年1月至2013年12月期间,马萨诸塞州医疗保险改革后,两个城市安全网学术医疗系统中不同种族/族裔患者的血糖控制变化。我们分析了三项血糖控制不佳指标的结果:1)在6个月期间未进行糖化血红蛋白(A1C)检测;2)A1C>8%;3)保险改革实施前、期间和之后A1C>9%。总体而言,我们未发现保险改革后A1C监测或控制率上升,特定种族/族裔群体也是如此。我们发现,在改革后时期,一些种族/族裔群体的血糖控制恶化而非改善。扩大可负担的保险覆盖范围与弱势群体血糖控制的改善无关。